Samsung Biologics

Samsung Biologics Co Ltd (Samsung Biologics) provides contract manufacturing services for the production of biopharmaceuticals. The company offers discovery and development services, non-GMP DS and cGMP DS DP production services, clinical manufacturing services and biosafety and analytical testing services, among others. It also offers fill and finish services. Samsung Biologics technology platform includes S-CHOice-high-performing cho-k1-based cell line development platform, S-DUAL – bispecific antibody platform and DEVELOPICK – developability assessment platform. The company owns manufacturing facilities for cell culture development, purification, quality control, and MSAT laboratory. Samsung Biologics is headquartered in Incheon, South Korea.

CDMO Services:
Analytical Services, API Biologics (Protein and Peptide), Clinical Dose, Clinical Packaging,Commercial Dose- Injectables, Commercial Packaging

Year Founded: 2011

Head Office: Yeonsu-Gu, Incheon, South Korea

Number of Facilities: 4

Facility locations: East Asia

Website: Visit the Samsung Biologics website

Linkedin: Connect on Linkedin